Arrowpoint Investment Partners (Singapore) Pte. Ltd.
Position in BIOA — BioAge Labs, Inc.
CIK 2032331
SINGAPORE, U0
Position in BIOA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$363,722
New position
Shares Held
20,796
first reported quarter
Ownership
0.047%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Arrowpoint Investment Partners (Singapore) Pte. Ltd. holds $4,293,255 across 4 Drug Manufacturers - Specialty & Generic names. BIOA ranks #3 (8.5% of the industry book) .
All Filings in BIOA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $363,722 | 20,796 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||